Tento zoznam vychádza zo zoznamov sledovaných titulov používateľov Stock Events, ktorí sledujú CRY. Nie je to investičné odporúčanie.
Konkurenti
Tento zoznam je analýza založená na nedávnych trhových udalostiach. Nejde o investičné odporúčanie.
O aplikácii
Artivion Inc., established in 1984 and based in Kennesaw, Georgia, functions globally as a manufacturer, processor, and distributor of both medical devices and implantable human tissues. Previously known as CryoLife, Inc., the company underwent a rebranding to Artivion Inc. in January 2022. Artivion caters to a wide array of clients, including physicians, hospitals, various healthcare facilities, and specialized surgeons in cardiac, vascular, thoracic, and general fields. Their comprehensive product portfolio features BioGlue, a polymer formulated from bovine blood protein for use in cardiac, vascular, pulmonary, and general surgical procedures. They also provide the On-X line of prosthetic aortic and mitral heart valves, alongside the On-X ascending aortic prosthesis. Artivion extends its services to include cardiac preservation and offers PhotoFix, a bovine pericardial patch, as well as the E-vita OPEN PLUS and E-vita OPEN NEO hybrid stent graft systems. The company is a prominent supplier of specialized stent grafts designed for numerous aortic and arterial conditions. These include the E-xtra DESIGN ENGINEERING products for aortic vascular diseases, E-nside as an off-the-shelf option for thoraco-abdominal disease, E-vita THORACIC 3G for endovascular treatment of thoracic aortic aneurysms, E-nya for minimally invasive repair of descending aorta lesions, E-ventus BX for renal and pelvic arteries, E-liac for aneurysmal iliac arteries and their side branches, and E-tegra for abdominal aortic aneurysms. Further offerings encompass synthetic vascular grafts for open aortic and peripheral surgeries, PerClot (an absorbable powdered hemostat), and cardiac laser therapy equipment such as the SolarGen 2100s Console. They also provide CryoVein and CryoArtery vascular preservation services, CarbonAid CO2 diffusion catheters, Chord-X ePTFE sutures for mitral chordal replacement, and ascyrus medical dissection stents. Additionally, Artivion provides pyrolytic carbon coating services to other manufacturers in the medical device industry.
Aká je dnes cena akcie spoločnosti GraniteShares YieldBOOST CRCL?▼
Aktuálna cena CRY je $22,27 USD — za posledných 24 hodín vzrástla o +1,08%. Vývoj ceny akcie spoločnosti GraniteShares YieldBOOST CRCL môžete podrobnejšie sledovať v grafe.
Aký ticker má akcia spoločnosti GraniteShares YieldBOOST CRCL?▼
Ticker akcie sa môže líšiť podľa burzy. Napríklad na burze sa akcie spoločnosti GraniteShares YieldBOOST CRCL obchodujú pod tickerom CRY.
Aká je trhová kapitalizácia spoločnosti GraniteShares YieldBOOST CRCL?▼
Aktuálne má spoločnosť GraniteShares YieldBOOST CRCL trhovú kapitalizáciu 875,35M
Vypláca GraniteShares YieldBOOST CRCL dividendy?▼
Áno, dividendy CRY sa vyplácajú týždenně. Posledná dividenda na akciu predstavovala 0,4 USD. K dnešnému dňu je dividendový výnos (FWD)% 94,87%.
Koľko má GraniteShares YieldBOOST CRCL zamestnancov?▼
Ku dňu júna 11, 2026 má spoločnosť 1 200 zamestnancov.
Do akého sektora patrí GraniteShares YieldBOOST CRCL?▼
GraniteShares YieldBOOST CRCL pôsobí v sektore Other.
Kedy spoločnosť GraniteShares YieldBOOST CRCL uskutočnila split akcií?▼
Spoločnosť GraniteShares YieldBOOST CRCL v poslednom čase neuskutočnila žiadny split akcií.